Q1 2018 13F Holders as of 3/31/2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
79.5M
-
Number of holders
-
144
-
Total 13F shares, excl. options
-
42.6M
-
Shares change
-
+4.49M
-
Total reported value, excl. options
-
$1.15B
-
Value change
-
+$141M
-
Put/Call ratio
-
0.95
-
Number of buys
-
77
-
Number of sells
-
-58
-
Price
-
$27.06
Significant Holders of PTC THERAPEUTICS, INC. - Common Stock (PTCT) as of Q1 2018
182 filings reported holding PTCT - PTC THERAPEUTICS, INC. - Common Stock as of Q1 2018.
PTC THERAPEUTICS, INC. - Common Stock (PTCT) has 144 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 42.6M shares
of 79.5M outstanding shares and own 53.66% of the company stock.
Largest 10 shareholders include SCOPIA CAPITAL MANAGEMENT LP (5.91M shares), RTW INVESTMENTS, LP (4.14M shares), BlackRock Inc. (3.28M shares), VANGUARD GROUP INC (2.96M shares), Boxer Capital, LLC (2.6M shares), D. E. Shaw & Co., Inc. (2.33M shares), STATE STREET CORP (2.16M shares), GREAT POINT PARTNERS LLC (1.54M shares), FMR LLC (1.12M shares), and WELLINGTON MANAGEMENT GROUP LLP (817K shares).
This table shows the top 144 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.